↓ Skip to main content

Dove Medical Press

Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study

Overview of attention for article published in OncoTargets and therapy, March 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
11 Mendeley
Title
Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study
Published in
OncoTargets and therapy, March 2021
DOI 10.2147/ott.s300987
Pubmed ID
Authors

Jianxin Chen, Haizhou Lou

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 18%
Researcher 1 9%
Other 1 9%
Unknown 7 64%
Readers by discipline Count As %
Medicine and Dentistry 3 27%
Immunology and Microbiology 1 9%
Agricultural and Biological Sciences 1 9%
Unknown 6 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2021.
All research outputs
#7,979,690
of 25,420,980 outputs
Outputs from OncoTargets and therapy
#435
of 3,019 outputs
Outputs of similar age
#173,073
of 451,458 outputs
Outputs of similar age from OncoTargets and therapy
#17
of 124 outputs
Altmetric has tracked 25,420,980 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,019 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.